Why is Medplus Health Services Ltd falling/rising?

Strong Price Momentum and Market Outperformance

Medplus Health Services has demonstrated remarkable resilience and growth in recent periods. Over the past week, the stock has surged by 8.78%, contrasting sharply with the Sensex’s decline of 2.70% during the same timeframe. This trend extends over longer horizons as well, with the stock appreciating 8.81% in the last month while the Sensex fell 3.68%. Year-to-date, Medplus has gained 18.06%, significantly outperforming the Sensex’s negative return of 11.71%. Even on a one-year basis, the stock has delivered a 16.64% return compared to the Sensex’s 8.84% loss. Such consistent outperformance highlights strong investor confidence in the company’s fundamentals and growth prospects.

On the day in question, the stock outperformed its sector by 5.74%, reaching an intraday high of ₹971.7, an 8.51% increase from the previous close. Despite a wide trading range of ₹95.7, the stock maintained upward momentum, supported by rising investor participation. Delivery volumes on 14 May rose by 13.12% compared to the five-day average, signalling increased buying interest. Furthermore, Medplus is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, reinforcing its bullish technical stance.

Robust Financial Metrics Underpinning the Rally

The company’s strong quarterly results have been a key driver behind the stock’s rise. Medplus has reported positive results for six consecutive quarters, underscoring consistent operational performance. Notably, the company’s Return on Capital Employed (ROCE) for the half-year period stands at an impressive 11.47%, indicating efficient utilisation of capital to generate profits. Additionally, the inventory turnover ratio is high at 4.91 times, reflecting effective inventory management and swift stock movement.

Net sales for the quarter reached a record ₹1,806.12 crore, signalling robust demand and revenue growth. This strong top-line performance has translated into substantial profit growth, with the company’s profits rising by 56.4% over the past year. Despite this growth, the stock trades at an attractive valuation, with an enterprise value to capital employed ratio of 4.8, which is lower than the average historical valuations of its peers. The company’s PEG ratio of 1 further suggests that the stock’s price is reasonably aligned with its earnings growth, making it an appealing proposition for investors.

Medplus’s ability to generate market-beating returns is evident when compared to the broader BSE500 index, which has declined by 1.67% over the last year. In contrast, Medplus has delivered a 16.64% return, highlighting its superior performance in a challenging market environment.

Investor Sentiment and Liquidity Support Continued Gains

Investor sentiment remains buoyant, as evidenced by the stock’s three-day consecutive gains, accumulating a 9.43% return in that period. The stock’s liquidity is sufficient to support sizeable trades, with the average traded value allowing for transactions up to ₹0.25 crore without significant price impact. This liquidity, combined with rising delivery volumes, suggests sustained investor interest and confidence in the company’s prospects.

While the weighted average price indicates that more volume was traded closer to the day’s low, the overall trend remains positive, supported by strong fundamentals and technical indicators. The wide intraday range reflects active trading and volatility, but the closing price near the day’s high confirms buying strength.

In summary, Medplus Health Services Ltd’s recent price rise is underpinned by a combination of strong financial results, attractive valuation metrics, consistent market outperformance, and increasing investor participation. These factors collectively contribute to the stock’s robust upward trajectory amid a broader market environment that has been less favourable.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →